{"entity":{"type":"insider","cik":"0001719114","url":"/insider/0001719114","json_url":"/insider/0001719114.json","name":"de Notaristefani Carlo","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2019-02-14","last":"2019-05-21","span_basis":"filed_date"},"name_variants":[{"name":"de Notaristefani Carlo","source":"filing","n_filings":4,"first_seen":"2019-02-14","last_seen":"2019-05-21"}],"transactions":[{"id":8453059,"accession":"0001209191-19-031609","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-031609","line_url":"/filing/0001209191-19-031609#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001719114","owner_name":"de Notaristefani Carlo","owner_display_name":"de Notaristefani Carlo","owner_url":"/insider/0001719114","role":"Officer (Executive VP Global Operations)","role_mark":"O","role_mark_label":"Officer (Executive VP Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP Global Operations","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16070.0,"shares_display":"16,070","price_per_share":11.42,"price_display":"11.42","price_state":"stated","total_value":183519.4,"total_display":"183,519.40","total_whole":"183,519","shares_owned_after":33588.727,"shares_owned_after_display":"33,588.73","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-20","filed_date":"2019-05-21","scope":"insider"},{"id":7789178,"accession":"0001209191-19-031213","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-031213","line_url":"/filing/0001209191-19-031213#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001719114","owner_name":"de Notaristefani Carlo","owner_display_name":"de Notaristefani Carlo","owner_url":"/insider/0001719114","role":"Officer (Executive VP Global Operations)","role_mark":"O","role_mark_label":"Officer (Executive VP Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP Global Operations","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":629.0,"shares_display":"629","price_per_share":11.76,"price_display":"11.76","price_state":"stated","total_value":7397.04,"total_display":"7,397.04","total_whole":"7,397","shares_owned_after":18783.727,"shares_owned_after_display":"18,783.73","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-16","filed_date":"2019-05-20","scope":"insider"},{"id":7787784,"accession":"0001209191-19-010835","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-010835","line_url":"/filing/0001209191-19-010835#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001719114","owner_name":"de Notaristefani Carlo","owner_display_name":"de Notaristefani Carlo","owner_url":"/insider/0001719114","role":"Officer (Executive VP Global Operations)","role_mark":"O","role_mark_label":"Officer (Executive VP Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP Global Operations","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3192.0,"shares_display":"3,192","price_per_share":17.669,"price_display":"17.67","price_state":"stated","total_value":56399.448,"total_display":"56,399.45","total_whole":"56,399","shares_owned_after":18208.727,"shares_owned_after_display":"18,208.73","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-14","filed_date":"2019-02-19","scope":"insider"},{"id":8596861,"accession":"0001209191-19-009989","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-009989","line_url":"/filing/0001209191-19-009989#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001719114","owner_name":"de Notaristefani Carlo","owner_display_name":"de Notaristefani Carlo","owner_url":"/insider/0001719114","role":"Officer (Executive VP Global Operations)","role_mark":"O","role_mark_label":"Officer (Executive VP Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP Global Operations","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5041.0,"shares_display":"5,041","price_per_share":17.875,"price_display":"17.88","price_state":"stated","total_value":90107.875,"total_display":"90,107.88","total_whole":"90,108","shares_owned_after":12120.727,"shares_owned_after_display":"12,120.73","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-13","filed_date":"2019-02-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","url":"/issuer/0000818686","role":"Officer (Executive VP Global Operations)","n_filings":4,"first_seen":"2019-02-14","last_seen":"2019-05-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001719114","retrieved_at":"2026-08-27T01:47:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}